Platinum
Beckman Coulter Ltd. Beckman Coulter is committed to advancing healthcare for every person by applying the power of science, technology and the passion and creativity of our teams to enhance the diagnostic laboratory’s role in improving healthcare outcomes. Our diagnostic systems are used in complex biomedical testing, and are found in hospitals, reference laboratories and physician office settings around the globe. Beckman Coulter offers a unique combination of people, processes and solutions designed to elevate the performance of clinical laboratories and healthcare networks. We do this by accelerating care with a menu that matters, bringing the benefit of automation to all, delivering greater insights through clinical informatics and unlocking hidden value through performance partnership. An operating company of Danaher Corporation (NYSE: DHR) since 2011, Beckman Coulter is headquartered in Brea, Calif., and has more than 11,000 global associates working diligently to make the world a healthier place.
The DxM Trio solution has a proven track record of accurate organism identification and antimicrobial susceptibility testing in the laboratory. Together, this integrated solution of technologies streamlines processes to enhance efficiency and take strides in antibiotic stewardship. › Combat emerging resistance with accurate detection › Improve laboratory efficiency with a reliable instrument that offers award-winning system performance › Reduce ancillary testing and lower costs with the DxM Trio › Fewest clinically significant limitations of any automated identification and antimicrobial susceptibility testing (ID/AST) system
Access IL-6 is a fully automated, chemiluminescent immunoassay for the quantitative measurement of IL-6 in human serum and plasma (heparin). When used in conjunction with other laboratory tests and clinical findings, it is a valuable tool for managing patients with COVID-19 through: › demonstrated clinical sensitivity of 85.4% to identify COVID-19 patients who are at risk for intubation with mechanical ventilation › efficient assessment and triage of COVID-19 patients by identifying patients who are at risk for intubation with mechanical ventilation › helping physicians better define appropriate treatment and allocate critical resources, (including mechanical ventilators) to the patients who need them most. The Access IL-6 EUA assay is available for use with all Access immunoassay platforms. The assay integrates seamlessly into your routine automated workflow and requires little maintenance, allowing you more time to focus on patient care.
DxH 560 AL Hematology Analyzer Save time and resources, eliminate unnecessary intervention and deliver high-quality results, even for difficult-to-draw patient groups, with the DxH 560. › Only 2+1 cleaner Reagents › 50 tube true continuous loading capacity › Only 17 µL Aspiration › Zero hands on daily cleaning › < 50 cm of counter width
D-
Booth No.